Skip to main content
. Author manuscript; available in PMC: 2016 Feb 1.
Published in final edited form as: Ann Surg. 2016 Feb;263(2):337–344. doi: 10.1097/SLA.0000000000001204

Table 1. Patient Demographics and Clinicopathologic Characteristics for the Training and Validation Sets.

Demographic or Clinical Characteristic Traning Set (n = 34) Validation Set (n = 81) P


No. Patients % No. Patients %
Hospital
 JHH 81
 JHBH 34
Age, mean ± SD 65.3 ± 12.8 66.8 ± 11.6 0.573
Sex
 Male 14 41.2 38 46.9
 Female 20 58.8 43 53.1
Localization 0.665
 Left colon 14 41.2 27 33.3
 Right colon 15 44.1 43 53.1
 Rectum 5 14.7 11 13.6
Tumor size, cm, mean + SD 4.7 ± 2.0 5.1 ± 2.5 0.402
Differentiation 0.261
 Well and moderate 26 76.5 69 85.2
 Poor 8 23.5 12 14.8
LNs examined, mean + SD 14.3 ± 6.2 14.3 ± 5.5 0.995
T4 tumors 0.101
 Yes 6 17.6 6 7.4
 No 28 82.4 75 92.6
Lymphovascular invasion 0.261
 Yes 8 23.5 12 14.8
 No 26 76.5 69 85.2
Mucin production 0.523
 Yes 5 14.7 16 19.8
 No 29 85.3 65 80.2
Recurrence 0.941
 Yes 12 35.3 28 34.6
 No 22 64.7 53 65.4
Recurrent type 1.000*
 Local 2 16.7 5 17.9
 Distant 10 83.3 23 82.1
Death 0.899
 Yes 13 38.2 32 39.5
 No 21 61.8 49 60.5
RFS, mo, mean + SD 61.0 ±41.2 59.0 ± 39.9 0.809
*

Fisher exact test.

SD indicates standard deviation.